GO:0009032 thymidine phosphorylase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0009032 thymidine phosphorylase activity catalyzes the reversible phosphorolysis of thymidine to thymine and 2-deoxy-D-ribose 1-phosphate [1,4].
• The enzyme is encoded by TYMP in humans and is also known as platelet-derived endothelial cell growth factor (PD-ECGF) [4,5].
• Thymidine phosphorylase activity is elevated in many solid tumors and correlates with angiogenesis, tumor growth, and poor prognosis [1,4,7,8].
• Loss-of-function mutations in TYMP cause mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) and can disrupt adipocyte differentiation leading to insulin-resistant lipoatrophic diabetes.
• The enzyme is a target for anticancer prodrugs such as capecitabine and 5-fluorouracil, which rely on its activity for activation or modulation.
• Research models include CRISPR knockout, point-mutation knock-in, and overexpression cell lines to dissect its role in cancer, metabolism, and angiogenesis [2,4].
Description
Thymidine phosphorylase activity (GO:0009032) is a molecular function that catalyzes the reversible phosphorolysis of thymidine to thymine and 2-deoxy-D-ribose 1-phosphate [1,4]. This enzymatic step is critical for pyrimidine nucleoside homeostasis and for the salvage pathway of thymidine. The enzyme is encoded by the TYMP gene in humans and is identical to the angiogenic factor platelet-derived endothelial cell growth factor (PD-ECGF) [4,5]. Beyond its catalytic role, thymidine phosphorylase activity has been implicated in angiogenesis, tumor progression, and mitochondrial DNA maintenance [4,5]. In cancer research, thymidine phosphorylase activity is a well-established biomarker and a target for prodrug activation, making it a focal point for both mechanistic studies and therapeutic development [4,8]. In metabolic and mitochondrial disorders, loss of thymidine phosphorylase activity leads to systemic nucleoside imbalance, as seen in MNGIE and lipoatrophic diabetes. Understanding the regulation and function of this enzyme is therefore essential for researchers in oncology, metabolism, and rare genetic diseases [2,4].
thymidine phosphorylase activity At A Glance
| GO ID | GO:0009032 |
|---|---|
| GO term | thymidine phosphorylase activity |
| Ontology | molecular_function |
| Synonym | pyrimidine phosphorylase activity; thymidine-orthophosphate deoxyribosyltransferase activity; thymidine:phosphate deoxy-alpha-D-ribosyltransferase activity; thymidine:phosphate deoxy-D-ribosyltransferase activity |
| Major function | Catalyzes the reversible phosphorolysis of thymidine to thymine and 2-deoxy-D-ribose 1-phosphate |
| Reaction | thymidine + phosphate = thymine + 2-deoxy-D-ribose 1-phosphate |
| Human gene | TYMP (also known as PD-ECGF, ECGF1) |
| Subcellular location | Cytosol, mitochondria, nucleus |
| Related diseases | MNGIE, lipoatrophic diabetes, cancer |
What Is GO:0009032?
Thymidine phosphorylase activity (GO:0009032) is defined as the catalysis of the reaction: thymidine + phosphate = thymine + 2-deoxy-D-ribose 1-phosphate [1,4]. This is a reversible phosphorolytic cleavage of the N-glycosidic bond of thymidine, yielding thymine and a phosphorylated deoxyribose moiety. The activity is classified under molecular_function in the Gene Ontology and is synonymous with pyrimidine phosphorylase activity, thymidine-orthophosphate deoxyribosyltransferase activity, and thymidine:phosphate deoxy-alpha-D-ribosyltransferase activity [1,4].
Why Is thymidine phosphorylase activity Important in Cell Biology?
Thymidine phosphorylase activity is important because it sits at the intersection of nucleoside metabolism, angiogenesis, and mitochondrial homeostasis [4,5]. Its catalytic product, 2-deoxy-D-ribose 1-phosphate, can be further metabolized to 2-deoxy-D-ribose, a known angiogenic factor. In cancer, high thymidine phosphorylase activity is associated with increased microvessel density and poor prognosis in several tumor types, including endometrial, ovarian, and prostate cancers [1,3,7,8]. The enzyme also activates the prodrug capecitabine to 5-fluorouracil, making it a predictive biomarker for chemotherapy response. In rare diseases, loss of thymidine phosphorylase activity causes MNGIE and has been linked to insulin-resistant lipoatrophic diabetes. Thus, understanding its regulation and function is critical for both therapeutic development and disease modeling [2,4].
• Elevated thymidine phosphorylase activity correlates with angiogenesis and poor prognosis in endometrial, ovarian, and prostate cancers [1,3,7,8].
• The enzyme is a target for anticancer prodrugs such as capecitabine, which requires thymidine phosphorylase for activation.
• Loss-of-function mutations in TYMP cause mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).
• Thymidine phosphorylase activity is essential for adipocyte differentiation and its loss induces insulin-resistant lipoatrophic diabetes.
• The enzyme regulates intracellular thymidine levels, which can affect mitochondrial DNA replication and repair [2,4].
• Thymidine phosphorylase activity is a potential biomarker for ovarian and endometrial tumors [7,8].
• It is involved in the salvage pathway of pyrimidine nucleosides, influencing nucleotide pool balance.
• Mycoplasma pneumoniae thymidine phosphorylase activity has been studied as a model for bacterial nucleoside metabolism.
• The enzyme's dual role in angiogenesis and chemoresistance makes it a multifaceted therapeutic target [4,5].
• CRISPR-based models of TYMP can help dissect its tissue-specific functions in cancer and metabolism [2,4].
Molecular Mechanism of thymidine phosphorylase activity
Substrate Binding and Catalytic Mechanism
In simple terms: The enzyme grabs thymidine and a phosphate molecule, then breaks thymidine into thymine and a sugar-phosphate.
Thymidine phosphorylase binds thymidine and inorganic phosphate in its active site. The catalytic mechanism involves nucleophilic attack by phosphate on the C1' of the deoxyribose ring, leading to cleavage of the N-glycosidic bond and formation of thymine and 2-deoxy-D-ribose 1-phosphate [1,4]. The reaction is reversible, allowing the enzyme to also catalyze the reverse phosphorolysis, synthesizing thymidine from thymine and 2-deoxy-D-ribose 1-phosphate. Structural studies have identified key residues that coordinate the phosphate and stabilize the transition state, though specific residues are not detailed in the provided citations.
Cofactors and Cofactor Requirements
In simple terms: The enzyme does not need any special helper molecules; it only needs phosphate to work.
Thymidine phosphorylase activity does not require any cofactors or metal ions for catalysis [1,4]. The reaction is driven solely by the presence of inorganic phosphate, which acts as the nucleophile. This simplicity distinguishes it from many other nucleoside phosphorylases that require divalent cations or coenzymes.
Regulation of Enzyme Activity
In simple terms: The amount and activity of the enzyme can go up or down in response to cell signals, especially in cancer and inflammation.
Thymidine phosphorylase activity is regulated at multiple levels. Transcriptional upregulation by cytokines, growth factors, and hypoxia has been reported in cancer cells. Inflammatory mediators such as TNF-alpha and IL-1 can induce TYMP expression. Post-translational modifications, including phosphorylation, may modulate enzyme activity, although specific sites are not detailed in the provided citations. In metabolic tissues, loss of thymidine phosphorylase activity disrupts adipocyte differentiation, suggesting a role in differentiation-dependent regulation.
Tissue Distribution and Isoforms
In simple terms: The enzyme is found in many tissues, with highest levels in the liver, placenta, and certain tumors.
Thymidine phosphorylase activity is widely distributed in human tissues, with high levels in the liver, placenta, and platelets. In normal endometrium, prostate, and ovarian tissues, activity is present but varies with the menstrual cycle and pathological state [1,3,7,8]. In cancer, enzyme activity is often elevated compared to adjacent normal tissue, as seen in endometrial and ovarian carcinomas [1,7,8]. No major isoforms have been described for the human enzyme, but species-specific differences exist, such as the Mycoplasma pneumoniae enzyme.
Subcellular Localization
In simple terms: The enzyme is found mainly in the cytoplasm but also in mitochondria and the nucleus.
Thymidine phosphorylase is predominantly a cytosolic enzyme, but it is also localized to mitochondria and the nucleus. Mitochondrial localization is critical for its role in mitochondrial nucleotide salvage and for the pathogenesis of MNGIE, where loss of activity leads to mitochondrial DNA depletion. Nuclear localization may be involved in regulating nucleoside pools for DNA replication and repair.
Key Genes Involved in GO:0009032 thymidine phosphorylase activity
The following genes and proteins are directly or indirectly involved in thymidine phosphorylase activity and its biological roles.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TYMP | Encodes thymidine phosphorylase; catalyzes thymidine phosphorolysis | Central to GO:0009032; mutations cause MNGIE and lipoatrophic diabetes [2,4] |
| PD-ECGF | Alternative name for TYMP; angiogenic factor | Used as a biomarker in cancer angiogenesis studies [4,5] |
| ECGF1 | Old symbol for TYMP | Historical literature reference |
| TP | Common abbreviation for thymidine phosphorylase | Used in enzyme activity assays [1,3,7,8] |
| UPP1 | Uridine phosphorylase 1; related pyrimidine phosphorylase | May compensate in pyrimidine salvage |
| DPYD | Dihydropyrimidine dehydrogenase; degrades thymine | Interacts with thymidine phosphorylase pathway in 5-FU metabolism |
| TYMS | Thymidylate synthase; de novo thymidine synthesis | Balances with salvage pathway |
| SLC29A1 | Equilibrative nucleoside transporter 1; transports thymidine | Affects substrate availability |
| SLC29A2 | Equilibrative nucleoside transporter 2 | Alternative thymidine transporter |
| NT5E | CD73; produces extracellular thymidine | May influence substrate pool |
| ADA | Adenosine deaminase; purine metabolism | Indirectly affects nucleoside balance |
| PNP | Purine nucleoside phosphorylase | Parallel enzyme in purine salvage |
| TK1 | Thymidine kinase 1; salvage pathway | Competes with thymidine phosphorylase for thymidine |
| TK2 | Thymidine kinase 2; mitochondrial salvage | Mitochondrial thymidine phosphorylation |
| POLG | Mitochondrial DNA polymerase | Affected by nucleotide imbalance in MNGIE |
| MPV17 | Mitochondrial inner membrane protein | Linked to mitochondrial DNA depletion |
| RRM2B | Ribonucleotide reductase subunit | Influences dNTP pools |
| CASP3 | Apoptosis executioner | Downstream of thymidine phosphorylase-mediated angiogenesis |
How Is thymidine phosphorylase activity Regulated?
Thymidine phosphorylase activity is regulated at transcriptional and post-transcriptional levels. In cancer cells, hypoxia, inflammatory cytokines (e.g., TNF-alpha, IL-1), and growth factors upregulate TYMP expression. The enzyme can also be regulated by phosphorylation, although specific sites are not detailed in the provided citations. In metabolic contexts, loss of thymidine phosphorylase activity disrupts adipocyte differentiation, indicating differentiation-dependent regulation. Additionally, substrate availability (thymidine and phosphate) and product inhibition may modulate activity in vivo.
thymidine phosphorylase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TYMP | MNGIE; mitochondrial DNA depletion | TYMP knockout cell lines, patient-derived fibroblasts |
| TYMP | Lipoatrophic diabetes; insulin resistance | Adipocyte differentiation models from TYMP KO cells |
| TYMP | Cancer angiogenesis; tumor growth | Xenograft models with TYMP overexpression or knockout [1,4] |
| TYMP | Ovarian cancer biomarker | Ovarian cancer cell lines with TYMP knockdown |
| TYMP | Endometrial cancer progression | Endometrial cancer organoids with TYMP mutations |
Thymidine phosphorylase activity in cancer and angiogenesis
Elevated thymidine phosphorylase activity is observed in many solid tumors, including endometrial, ovarian, and prostate cancers [1,3,7,8]. High enzyme activity correlates with increased intratumoral microvessel density, suggesting a role in angiogenesis [1,5]. The angiogenic effect is mediated in part by the product 2-deoxy-D-ribose, which stimulates endothelial cell chemotaxis and proliferation. In ovarian cancer, thymidine phosphorylase activity has been proposed as a tumor marker. In endometrial cancer, cytosolic activity is significantly higher in malignant versus normal tissue. These findings support thymidine phosphorylase as a therapeutic target and biomarker.
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)
Loss-of-function mutations in TYMP cause MNGIE, an autosomal recessive disorder characterized by mitochondrial DNA depletion, gastrointestinal dysmotility, and neurological symptoms. The absence of thymidine phosphorylase activity leads to systemic accumulation of thymidine and deoxyuridine, which imbalances mitochondrial nucleotide pools and impairs mtDNA replication. This condition highlights the critical role of thymidine phosphorylase in mitochondrial homeostasis.
Lipoatrophic diabetes and metabolic dysfunction
Recent studies have shown that loss of thymidine phosphorylase activity disrupts adipocyte differentiation and induces insulin-resistant lipoatrophic diabetes. This suggests that the enzyme plays a role in adipose tissue biology beyond nucleoside metabolism. The mechanism may involve altered intracellular thymidine levels affecting differentiation pathways.
From thymidine phosphorylase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of thymidine phosphorylase activity impair mitochondrial function? | TYMP knockout in HeLa or HEK293 cells |
| How does thymidine phosphorylase activity affect angiogenesis? | Endothelial tube formation assay with TYMP-overexpressing cancer cells |
| What is the role of thymidine phosphorylase in adipocyte differentiation? | CRISPR knockout of TYMP in 3T3-L1 preadipocytes |
| Can point mutations in TYMP mimic MNGIE? | Knock-in of patient-specific TYMP mutations in iPSCs |
| Does thymidine phosphorylase activity predict capecitabine response? | Patient-derived xenografts with varying TYMP expression |
| What is the subcellular localization of thymidine phosphorylase? | Tagged knock-in of TYMP with GFP in cancer cell lines |
How to Study the thymidine phosphorylase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Spectrophotometric assay | Thymidine phosphorylase enzyme activity | Tumor tissue lysates [1,3,7,8] |
| HPLC | Thymidine and thymine levels | Enzyme kinetics and metabolomics |
| qRT-PCR | TYMP mRNA expression | Cancer biomarker studies |
| Western blot | Thymidine phosphorylase protein levels | Tissue and cell line analysis |
| Immunohistochemistry | Protein localization and expression | Clinical tumor samples [1,8] |
| LC-MS/MS metabolomics | Nucleoside and nucleotide pools | Metabolic disease models |
| CRISPR knockout | Loss-of-function phenotypes | Mitochondrial and adipocyte studies |
| CRISPR knock-in | Point mutation effects | MNGIE modeling |
Enzyme Activity Assays
Thymidine phosphorylase activity is typically measured using spectrophotometric or HPLC-based assays that monitor the conversion of thymidine to thymine [1,3,7,8]. These assays can be performed on cell lysates or purified enzyme and are used to quantify activity in normal and neoplastic tissues [1,7,8].
Gene Expression Analysis
Quantitative RT-PCR and RNA-seq are used to measure TYMP mRNA levels in tissues and cell lines. Immunohistochemistry and Western blotting detect protein expression and localization. These methods help correlate enzyme activity with clinical outcomes [1,8].
CRISPR-Cas9 Genome Editing
CRISPR knockout, point mutation knock-in, and tagged knock-in of TYMP are used to dissect its function in cancer, metabolism, and mitochondrial biology [2,4]. These models enable precise interrogation of catalytic activity and non-catalytic roles.
Metabolomics and Nucleoside Profiling
LC-MS/MS-based metabolomics quantifies thymidine, thymine, and 2-deoxy-D-ribose 1-phosphate levels in cells and tissues [2,4]. This approach reveals how thymidine phosphorylase activity affects nucleotide pools and metabolic pathways.
How CRISPR Can Be Used to Study GO:0009032 thymidine phosphorylase activity
Knockout
CRISPR knockout of TYMP eliminates thymidine phosphorylase activity, enabling studies of its role in mitochondrial DNA maintenance, adipocyte differentiation, and tumor angiogenesis [2,4]. TYMP knockout cell lines show accumulation of thymidine and impaired mitochondrial function, mimicking MNGIE.
Point Mutation
Point mutations in TYMP identified in MNGIE patients can be introduced via CRISPR knock-in to study their impact on enzyme activity and stability. These models help distinguish catalytic from non-catalytic functions.
Knock-in
Tagged knock-in of TYMP with fluorescent or affinity tags allows real-time tracking of enzyme localization and interaction partners. This approach is useful for studying subcellular trafficking and complex formation.
Overexpression
Overexpression of TYMP in cancer cell lines or endothelial cells is used to study its angiogenic and chemoresistance properties [4,5]. Such models help identify downstream effectors and potential therapeutic targets.
How EDITGENE Supports thymidine phosphorylase activity Research
Researchers studying thymidine phosphorylase activity-related genes often need to determine whether a candidate gene is causally involved in nucleoside metabolism, angiogenesis, or mitochondrial function. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for thymidine phosphorylase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TYMP Knockout HEK293 Cell Line | EDJ-KQ2212 | Human | 1890 | Details Get a Quote |
| UPP1 Knockout HEK293 Cell Line | EDJ-KQ2442 | Human | 7378 | Details Get a Quote |
| UPP2 Knockout HEK293 Cell Line | EDJ-KQ10663 | Human | 151531 | Details Get a Quote |
| UPP1 Knockout A-549 Cell Line | EDJ-KQ22954 | Human | 7378 | Details Get a Quote |
| UPP1 Knockout HCT 116 Cell Line | EDJ-KQ22955 | Human | 7378 | Details Get a Quote |
| UPP1 Knockout HeLa Cell Line | EDJ-KQ22956 | Human | 7378 | Details Get a Quote |
| TYMP Knockout A-549 Cell Line | EDJ-KQ22468 | Human | 1890 | Details Get a Quote |
| TYMP Knockout HCT 116 Cell Line | EDJ-KQ22469 | Human | 1890 | Details Get a Quote |
| TYMP Knockout HeLa Cell Line | EDJ-KQ22470 | Human | 1890 | Details Get a Quote |
| UPP2 Knockout HeLa Cell Line | EDJ-KQ58690 | Human | 151531 | Details Get a Quote |
| UPP2 Knockout A-549 Cell Line | EDJ-KQ67173 | Human | 151531 | Details Get a Quote |
| UPP2 Knockout HCT 116 Cell Line | EDJ-KQ75575 | Human | 151531 | Details Get a Quote |
Displaying Records 1 To 12 Of 12 Records
Frequently Asked Questions About thymidine phosphorylase activity
What is thymidine phosphorylase activity?
Thymidine phosphorylase activity (GO:0009032) is the catalysis of the reversible phosphorolysis of thymidine to thymine and 2-deoxy-D-ribose 1-phosphate [1,4].
What gene encodes thymidine phosphorylase activity?
The human TYMP gene (also known as PD-ECGF or ECGF1) encodes thymidine phosphorylase.
What diseases are associated with thymidine phosphorylase activity?
Altered activity is linked to cancer (endometrial, ovarian, prostate), MNGIE, and lipoatrophic diabetes [1,2,3,7,8].
How is thymidine phosphorylase activity measured?
It is measured using spectrophotometric or HPLC assays that detect thymine formation from thymidine [1,3,7,8].
What is the role of thymidine phosphorylase in angiogenesis?
The enzyme produces 2-deoxy-D-ribose, which stimulates endothelial cell migration and angiogenesis.
What is MNGIE?
MNGIE is mitochondrial neurogastrointestinal encephalomyopathy, caused by loss-of-function mutations in TYMP.
Can thymidine phosphorylase activity be targeted for cancer therapy?
Yes, it activates capecitabine to 5-fluorouracil and is a target for prodrug therapy.
What are the substrates of thymidine phosphorylase?
Thymidine and inorganic phosphate are the substrates; thymine and 2-deoxy-D-ribose 1-phosphate are the products [1,4].
Is thymidine phosphorylase activity found in bacteria?
Yes, Mycoplasma pneumoniae thymidine phosphorylase has been studied as a bacterial model.
How can CRISPR be used to study thymidine phosphorylase activity?
CRISPR knockout, knock-in, and overexpression models allow precise dissection of its roles in cancer, metabolism, and mitochondrial function [2,4].
Conclusion
Thymidine phosphorylase activity (GO:0009032) is a multifunctional enzyme activity critical for nucleoside metabolism, angiogenesis, and mitochondrial homeostasis [4,5]. Its dysregulation is implicated in cancer progression, MNGIE, and metabolic disorders, making it a valuable target for therapeutic development and biomarker discovery [1,2,4,8]. CRISPR-based models and advanced analytical methods continue to unravel its complex biology, offering new opportunities for intervention [2,4].
References
- 1. Sivridis E. 2000. Thymidine phosphorylase activity in normal, hyperplastic and neoplastic endometrium--correlation with intratumoral angiogenesis.. Adv Exp Med Biol 476:297-303 PMID: 10949674
- 2. Gautheron J et al.. 2022. Loss of thymidine phosphorylase activity disrupts adipocyte differentiation and induces insulin-resistant lipoatrophic diabetes.. BMC Med 20(1):95 PMID: 35341481
- 3. Touffet S et al.. 1992. [Demonstration of thymidine phosphorylase activity in human healthy, adenomatous and cancerous prostate].. Bull Cancer 79(2):151-9 PMID: 1382732
- 4. Warfield BM et al.. 2022. Multifunctional role of thymidine phosphorylase in cancer.. Trends Cancer 8(6):482-493 PMID: 35193822
- 5. Brown NS et al.. 1998. Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis.. Biochem J 334 ( Pt 1)(Pt 1):1-8 PMID: 9693094
- 6. Wang L et al.. 2014. Mycoplasma pneumoniae thymidine phosphorylase.. Nucleosides Nucleotides Nucleic Acids 33(4-6):296-304 PMID: 24940683
- 7. Miszczak-Zaborska E et al.. 2008. The cytosol activity of thymidine phosphorylase in endometrial cancer.. J Exp Clin Cancer Res 27(1):64 PMID: 18986516
- 8. Miszczak-Zaborska E et al.. 2004. The activity of thymidine phosphorylase as a new ovarian tumor marker.. Gynecol Oncol 94(1):86-92 PMID: 15262124
